Purchases and Sales Made in Q1 2023 in United Therapeutics Corp (UTHR)
This table provides information about the institutional ownership of United Therapeutics Corp (UTHR) during Q1 2023. The information is specifically focused on institutions that hold shares of UNITED THERAPEUTICS Corp.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2023
Q1 2023
|
Captrust Financial Advisors
Raleigh, NC |
SELL
|
- |
-152K- 91.44% |
$32.3M - $41.9M
|
14.2K
$5.08M
|
|
|
May 15, 2023
Q1 2023
|
Frontier Capital Management CO LLC
|
SELL
|
- |
-165K- 72.96% |
$35.2M - $45.7M
|
61.3K
$22M
|
|
|
May 11, 2023
Q1 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-177K- 56.61% |
$37.6M - $48.8M
|
135K
$48.5M
|
|
|
May 14, 2024
Q1 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-177K- 56.61% |
$37.6M - $48.8M
|
135K
$48.5M
|
|
|
May 15, 2023
Q1 2023
|
Fred Alger Management, LLC
New York, NY |
SELL
|
- |
-183K- 99.91% |
$39.1M - $50.6M
|
161
$57.7K
|
|
|
May 15, 2023
Q1 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-250K- 49.27% |
$53.3M - $69.2M
|
258K
$92.4M
|
|
|
May 15, 2023
Q1 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-271K- 83.35% |
$57.7M - $74.8M
|
54.1K
$19.4M
|